NEWARK, Del, June 26, 2024 (GLOBE NEWSWIRE) -- The IV therapy and vein access devices market is expected to reach USD 28.7 billion by 2024. From 2024 to 2034, revenue is expected to increase by 5.1% ...

This report provides an in-depth analysis of the global IV therapy and venous access market, covering applications across various healthcare settings. It studies IV solutions, infusion pumps and ...

One in five patients referred for vascular access surgery experience an unsustainable treatment burden, with poor health ...

Axillary vein access has emerged as a safe and efficient alternative for cardiac device implantation. By utilising the anatomical course of the axillary vein, clinicians can facilitate the insertion ...

Xeltis’ vascular access graft, aXess, recently demonstrated strong efficacy in an EU pivotal trial in patients with end-stage renal disease.

Argon Medical Devices — a manufacturer of medical device solutions for interventional radiology, vascular surgery, interventional cardiology, and oncology — recently introduced its Traveler Portal ...

A simple reversal of the way a long-standing surgical procedure is performed to create an arteriovenous fistula for hemodialysis access significantly improves the fistula's function and longevity over ...

This field refers to the type of vascular access used to dialyze the patient during the last treatment that the user’s facility provided that patient during the reporting month. This field allows the ...

Dr. Saurabh Joshi performs Tanzania’s first VenaSeal procedure, advancing minimally invasive varicose vein treatment through ...

The MarketWatch News Department was not involved in the creation of this content. "Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly ...